BMEA vs VTRS · $94.7M cap vs rev $14.74B
Biomea Fusion Inc (BMEA) versus Viatris Inc (VTRS) — a side-by-side from cached financials, not a winner call.
Biomea Fusion Inc (BMEA) is a biotechnology company listed on US.
Viatris Inc (VTRS) is a drug manufacturers - specialty & generic company listed on US.
BMEA does not have a complete income-statement cache yet.
Latest reported VTRS revenue for 2024-12-31 was $14.74B. Net income was -$634.2M. Revenue was down 4.5% from 2023-12-31 to 2024-12-31. VTRS currently screens at market cap $10.83B.
BMEA currently screens at market cap $94.7M. VTRS currently screens at market cap $10.83B.
Not investment advice. Open the BMEA and VTRS stock pages for the full models.
Not investment advice.